PhAST Diagnostics

About:

PhAST Diagnostics develops rapid diagnostic technology to provide actionable information on pathogens.

Website: https://phastdiagnostics.com

Top Investors: Massachusetts Life Sciences Center

Description:

PhAST Diagnostics develops an AI imaging technology for combating antibiotic resistance. Its cloud-based platform provides clinical decision support for doctors, workflow improvement for hospitals, and helps accelerate the drug development process for pharmaceutical companies.

Total Funding Amount:

$15.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)phastdiagnostics.com

Founders:

Kwangmin Son, Roman Stocker

Number of Employees:

11-50

Last Funding Date:

2022-12-14

IPO Status:

Private

© 2024 MyAiNote.com